0001628280-22-003056.txt : 20220217 0001628280-22-003056.hdr.sgml : 20220217 20220217170017 ACCESSION NUMBER: 0001628280-22-003056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucera Erick CENTRAL INDEX KEY: 0001697616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 22649086 MAIL ADDRESS: STREET 1: 138 THISTLE ROAD CITY: NORTH ANDOVER STATE: MA ZIP: 08145 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043581650 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 WINTER STREET CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 857-400-0101 MAIL ADDRESS: STREET 1: 30 WINTER STREET CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: AVEO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20050503 4 1 wf-form4_164513518447933.xml FORM 4 X0306 4 2022-02-15 0 0001325879 AVEO PHARMACEUTICALS, INC. AVEO 0001697616 Lucera Erick C/O AVEO PHARMACEUTICALS, INC. 30 WINTER STREET BOSTON MA 02108 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.67 2022-02-15 4 A 0 218800 0 A 2032-02-15 Common Stock 218800.0 218800 D The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company. /s/ Danielle V. Holland, attorney-in-fact 2022-02-17